Systematic Financial Management LP Taro Pharmaceutical Industries LTD Transaction History

Systematic Financial Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$54.41 - $68.2 $235,595 - $295,306	-4,330 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$61.66 - $70.16 $89,715 - $102,082	-1,455 Reduced 25.15%	4,330 $288,000
Q1 2020 May 12, 2020	SELL	$59.35 - $88.73 $43,325 - $64,772	-730 Reduced 11.2%	5,785 $354,000
Q4 2019 Feb 14, 2020	SELL	$74.18 - $97.92 $48,958 - $64,627	-660 Reduced 9.2%	6,515 $573,000
Q3 2019 Nov 06, 2019	SELL	$75.36 - $86.57 $110,025 - $126,392	-1,460 Reduced 16.91%	7,175 $541,000
Q2 2019 Jul 26, 2019	SELL	$83.92 - $108.88 $318,896 - $413,744	-3,800 Reduced 30.56%	8,635 $738,000
Q1 2019 May 03, 2019	SELL	$85.97 - $108.09 $14,185 - $17,834	-165 Reduced 1.31%	12,435 $1.34 Million
Q4 2018 Feb 13, 2019	BUY	$78.25 - $107.92 $64,556 - $89,034	825 Added 7.01%	12,600 $1.07 Million
Q3 2018 Nov 06, 2018	SELL	$97.82 - $116.09 $5,380 - $6,384	-55 Reduced 0.46%	11,775 $1.16 Million
Q2 2018 Aug 08, 2018	SELL	$97.62 - $120.59 $216,228 - $267,106	-2,215 Reduced 15.77%	11,830 $1.37 Million
Q1 2018 May 09, 2018	BUY	$95.91 - $107.26 $1.35 Million - $1.51 Million	14,045 New	14,045 $1.39 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.